94 related articles for article (PubMed ID: 32695218)
1. Overexpression of programmed cell death ligand 1 in patients with CIN and its correlation with human papillomavirus infection and CIN persistence.
Sancakli Usta C; Altun E; Afsar S; Bulbul CB; Usta A; Adalı E
Infect Agent Cancer; 2020; 15():47. PubMed ID: 32695218
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
3. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization.
Chang H; Hong JH; Lee JK; Cho HW; Ouh YT; Min KJ; So KA
J Gynecol Oncol; 2018 May; 29(3):e27. PubMed ID: 29400020
[TBL] [Abstract][Full Text] [Related]
5. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
Front Immunol; 2020; 11():612547. PubMed ID: 33552075
[TBL] [Abstract][Full Text] [Related]
6. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
7. Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection.
Nam EJ; Kim JW; Hong JW; Jang HS; Lee SY; Jang SY; Lee DW; Kim SW; Kim JH; Kim YT; Kim S; Kim JW
J Gynecol Oncol; 2008 Sep; 19(3):162-8. PubMed ID: 19471565
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia.
Nuovo GJ; Blanco JS; Leipzig S; Smith D
Obstet Gynecol; 1990 Jun; 75(6):1006-11. PubMed ID: 2160630
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of programmed death-1 on lymphocytes and programmed death ligand-1 on monocytes in the peripheral blood of patients with cervical cancer.
Zhang Y; Zhu W; Zhang X; Qu Q; Zhang L
Oncol Lett; 2017 Dec; 14(6):7225-7231. PubMed ID: 29344157
[TBL] [Abstract][Full Text] [Related]
10. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of p16 in Epithelial Ovarian Cancer for a 10-Year Study in Northeast China: Significance of HPV in Correlation with PD-L1 Expression.
Yang X; You Q; Yao G; Geng J; Ma R; Meng H
Cancer Manag Res; 2020; 12():6747-6753. PubMed ID: 32848457
[TBL] [Abstract][Full Text] [Related]
12. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
13. High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women.
Papasavvas E; Surrey LF; Glencross DK; Azzoni L; Joseph J; Omar T; Feldman MD; Williamson AL; Siminya M; Swarts A; Yin X; Liu Q; Firnhaber C; Montaner LJ
Oncoimmunology; 2016 May; 5(5):e1128612. PubMed ID: 27467943
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
15. CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts
Chen X; He H; Xiao Y; Hasim A; Yuan J; Ye M; Li X; Hao Y; Guo X
Front Oncol; 2021; 11():629350. PubMed ID: 34422627
[TBL] [Abstract][Full Text] [Related]
16. Increased PD-1 Level in Severe Cervical Injury Is Associated With the Rare Programmed Cell Death 1 (
da Silva MC; Medeiros FS; da Silva NCH; Paiva LA; Gomes FODS; Costa E Silva M; Gomes TT; Peixoto CA; Rygaard MCV; Menezes MLB; Welkovic S; Donadi EA; Lucena-Silva N
Front Cell Infect Microbiol; 2021; 11():587932. PubMed ID: 34290992
[TBL] [Abstract][Full Text] [Related]
17. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
[TBL] [Abstract][Full Text] [Related]
18. Cervical FISH Testing for Triage and Support of Challenging Diagnoses: A Case Study of 2 Patients.
Hopley R; Gillespie A
Lab Med; 2016 Feb; 47(1):52-6. PubMed ID: 26732782
[TBL] [Abstract][Full Text] [Related]
19. Hybrid capture II for high-risk human papillomavirus DNA testing to detect cervical precancerous lesions: A qualitative and quantitative study.
Ma L; Bian ML; Cheng JY; Xiao W; Hao M; Zhu J; Chen Y; Liu J
Exp Ther Med; 2010 Jan; 1(1):193-198. PubMed ID: 23136614
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy.
Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN
Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
